BRACHYTHERAPY MARKET ANALYSIS

Regional Analysis

On the basis of region, the global brachytherapy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position, owing to the rising adoption of breast microseed treatment for breast cancer. Using brachytherapy, breast microseed treatment involves the precise placement of radioactive seeds in the breast that slowly release the prescribed dose safely over the period. This is an innovative treatment for early stage breast cancer, which affects 1 in 8 women in North America. For instance, According to the Centers for Disease Control and Prevention, in 2014, around 236,968 women and 2,141 men were diagnosed with breast cancer in the U.S. Furthermore, Asia Pacific is expected to be the key region in the global brachytherapy market, owing to the launch of Esteya Machine in 2016, for skin cancer treatment. The treatment uses low energy x-rays to target the cancerous site, with the ability to treat multiple lesions at once and a reduced chance of scarring.

Market Taxonomy:

The global brachytherapy market is segmented on the basis of type, application, and geography